Beijing Tiantan Biological Products Corp Ltd Asset Resilience Ratio

Latest as of June 2024: 8.08%

Beijing Tiantan Biological Products Corp Ltd asset resilience ratio. Beijing Tiantan Biological Products Corp Ltd (600161) has an Asset Resilience Ratio of 8.08% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Tiantan Biological Products Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.22 Billion

≈ $179.01 Million USD Cash + Short-term Investments

Total Assets

CN¥15.14 Billion

≈ $2.22 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Beijing Tiantan Biological Products Corp Ltd (None–None)

Asset resilience ratio of Beijing Tiantan Biological Products Corp Ltd from None to None. This chart shows how Beijing Tiantan Biological Products Corp Ltd's Asset Resilience Ratio has changed over time. Read 600161 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Beijing Tiantan Biological Products Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Beijing Tiantan Biological Products Corp.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.22 Billion	8.08%
Total Liquid Assets	CN¥1.22 Billion	8.08%

Asset Resilience Insights

Limited Liquidity: Beijing Tiantan Biological Products Corp Ltd maintains only 8.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Beijing Tiantan Biological Products Corp Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Tiantan Biological Products Corp Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
3SBio Inc F:83B	Biotechnology	10.64%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.12%

Beijing Tiantan Biological Products Corp Ltd Asset Resilience Ratio by Year (None–None)

Beijing Tiantan Biological Products Corp Ltd asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Beijing Tiantan Biological Products Corp Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology

Market Cap

$3.67 Billion

CN¥25.05 Billion CNY

Market Cap Rank

#4207 Global

#602 in China

Share Price

CN¥12.67

Change (1 day)

-1.48%

52-Week Range

CN¥11.41 - CN¥18.64

All Time High

CN¥74.24